Signed up to the Chris Head of X Direct Potential 13/3/18 Ongoing Disclosed on following rebate Lawson Medicines conflict with CCG register schemes on behalf of Optimisation. Area and will be the CCG: - Prescribing disclosed on Rivaroxaban Committee any meetings (Xarelto) Guidance or projects if / Leuprorelin Decisions when involved (Prostap) in Goserelin (Zoladex) Oxis (formoterol) Turnohaler Ebesque XL (quetiapine MR) Fencino (fentanyl patches) Luventa XL (galantamine XL) Repinex (ropinirole MR) Lixiana (edoxaban) Carbocisteine sachets GlucoRx Airflusal
Chris Lawson Head of Medicines Optimisation. Signed up to the following rebate schemes on behalf of the CCG: - Rivaroxaban (Xarelto) Leuprorelin (Prostap) Goserelin (Zoladex) Oxis (formoterol) Turnohaler Ebesque XL (quetiapine MR) Fencino (fentanyl patches) Luventa XL (galantamine XL) Repinex (ropinirole MR) Lixiana (edoxaban) Carbocisteine sachets GlucoRx Airflusal X Direct Potential conflict with Area Prescribing Committee Guidance Decisions 13/3/18 Ongoing Disclosed on CCG register and will be disclosed on any meetings or projects if / when involved in
All%20Staff%20Register%20of%20Interests.docx